Related Experiment Videos
[Limb lengthening in children with osteogenesis imperfecta]
1Oddział Ortopedyczno-Urazowy Katedry i Kliniki Chirurgii Pediatrycznej Uniwersyteckiego Szpitala Dzieciecego, Wydział Lekarski Uniwersytetu Jagiellońskiego.
Summary
Lower limb lengthening in children with osteogenesis imperfecta type I is possible, despite high complication rates. This surgical approach can correct leg length discrepancies, improving patient outcomes.
Area of Science:
- Orthopedic Surgery
- Pediatric Orthopedics
- Genetics and Bone Diseases
Background:
- Osteogenesis imperfecta (OI) type I presents with brittle bones and can cause significant lower limb length discrepancies in children.
- Managing leg length discrepancies in pediatric OI patients requires specialized surgical techniques.
Purpose of the Study:
- To evaluate the feasibility and outcomes of lower limb lengthening in children with osteogenesis imperfecta type I.
- To assess the effectiveness of Ilizarov and Wagner techniques in correcting limb length discrepancies.
Main Methods:
- Seven children (5 girls, 2 boys) with OI type I underwent lower limb lengthening procedures.
- Ilizarov and Wagner techniques were employed for femur and tibia elongations, with intramedullary Rush rods used in most cases.
- Osteotomies were performed in metaphyseal or distal regions, with controlled daily elongation of 1 mm.
Main Results:
- A mean bone lengthening of 5.5 cm was achieved, resulting in a mean limb lengthening of 7.9 cm.
- The mean elongation period was 2.8 months, with an elongation index of 26 days/cm.
- Complications were observed in all patients, highlighting the inherent risks of the procedure.
Conclusions:
- Lower limb lengthening is a viable option for children with OI type I, enabling equalization or reduction of leg length discrepancies.
- Despite a high incidence of complications, the benefits of limb equalization justify the surgical intervention.
- Careful surgical planning and execution are crucial for managing this challenging patient population.